Myungmoon Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Myungmoon Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Whanin Pharmaceutical Company Limited
sales of 147.95 billion Korean Won [US$138.19 million]
Hyundai Pharmaceutical Company Limited
(130.48 billion Korean Won [US$121.87 million]
of which 88%
was Pharmaceutical), and
Dae Han New Pharm Co., Ltd.
(130.82 billion Korean Won [US$122.18 million]
During the year ended December of 2017, sales at
Myungmoon Pharmaceutical Company Limited were 140.14 billion Korean Won (US$130.89 million).
decrease of 1.4%
versus 2016, when the company's sales were 142.18 billion Korean Won.